“Problem, intensive drug use and polydrug use” Introduction Danica Klempova, Scientific Committee meeting, Lisbon, 17 November.

Slides:



Advertisements
Similar presentations
TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.
Advertisements

M. Fe Caces, Ph.D. Statistician/Demographer Office of National Drug Control Policy Executive Office of the President Washington, DC Presentation for the.
Etienne Maffli Swiss Institute for the Prevention of Alcohol and other Drug Problems Lausanne, Switzerland Characteristics of male and female outpatients.
Problem drug use – conceptual and methodical considerations Rehm, J.1,2,3,4 1Technische Universität Dresden 2 Centre for Addiction and Mental Health, Toronto,
REPORT Full report Executive summary Methodology STATISTICAL ANNEX Seizures Drug use Prices Illicit laboratories.
Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.
Canadian Centre on Substance Abuse Heather Clark, April 21 st, 2008 A Coordinated Approach to Student Drug Use Surveys.
Monitoring Trends in Illicit Drug Use in Australia Wayne Hall School of Population Health, University of Queensland and Louisa Degenhardt and Natasha Sindicich.
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
Heavy or problematic drug use, heavy and problematic to define? Iceland August 2010, Nordic Alcohol and Drug Researchers’ Assembly Ellen J. Amundsen,
Problem drug use, HIV and injecting: an overview of the European experience Paul Griffiths, EMCDDA Drug Control in the Baltic Region, Vilnius, 27 September.
Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.
J. Rehm (TU Dresden). Person goes up in a hot air balloon; it gets cloudy; he doesn’t know where he is; finally there is a break in the clouds, luckily,
Module 4: Interaction of. Objectives To be aware of the possible reasons why dual diagnosis occurs To be aware of the specific effects of substances on.
Strenghtening collaboration with Serbia - IPA4 Project expected outcomes Frédéric Denecker, Programme Management Officer Reitox and International Cooperation.
Topic 1 Basic Drug Information Slide 1.1. The drugs of most concern to the community are those that affect the central nervous system (brain and spinal.
Drug Trends in Washington State & King County Caleb J. Banta-Green MPH MSW Alcohol & Drug Abuse Institute University of Washington
Advanced Briefing to Member States
Presentation Package for Concepts of Fitness and Wellness 6e Section VII: Concept 22 Use and Abuse of Other Drugs.
+ Opioid Substitution Therapy for Injecting Drug Users: Scale versus Quality WORKSHOP “OST in Developing Countries: A Primer” Atul Ambekar, Alok Agrawal.
ARQ part II data management Training pack 4: Terminology.
ARQ part II data management Training pack 1: Content and conceptual issues.
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
Meeting of the National Drug Observatories in the Caribbean DRUG CONSUMPTION SITUATION IN THE CARIBBEAN Pernell Clarke Coordinator of Information and Research.
Spring 2011 Molly Bell, Colleen Dell, and Randy Duncan Emerging Trends in Alcohol and Drug Use in Saskatoon: Highlights.
LEGAL AND ILLEGAL SUBSTANCES. LEGAL DRUGS Legal drugs are considered permissible for use, and are either prescribed by a physician (prescription medications)
JUST SAY KNOW: FACTS ABOUT PSYCHOACTIVE DRUGS Rick Csiernik, King’s University College at Western University
Estimation of the Prevalence of Problem Drug Use in Lithuania Dr Gordon Hay Centre for Drug Misuse Research University of Glasgow, United Kingdom.
National Research and Development Centre for Welfare and Health Knowledge for welfare and health1 Finnish Drug Treatment Information System Kristiina Kuussaari,
North Carolina TASC Clinical Series Training Module Eight: DSM -IV.
Harm Reduction.
Treatment system-based data collection: an integrated approach to monitoring Expert meeting: Implementation of the treatment strategy EMCDDA Lisbon,
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
Impact of Inhalant Use in Venezuela Elvia Amesty, MGSc Jose Felix Ribas Foundation.
Problem alcohol use among drug users: Clinical guidelines development for primary care Jan Klimas, Catherine Anne Field, Walter Cullen & Guideline Development.
Annual report 2010: the state of the drugs problem in Europe.
Annual report 2009: the state of the drugs problem in Europe International Conference: New trends in drug use: facts and solutions, Parliament of the Republic.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
Nova Scotia Student Drug Use Survey Methods Anonymous confidential self-reported survey Approved by Ethics Review Board Students in grades 7, 9,
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
Drugs and Alcohol Needs Assessment 2011/12: Dissemination of findings.
Erik Iversen, Norway Workshop at the annual TDI expert meeting EMCDDA, Lisbon 25 September 2006 Data Coverage Assessment The Bergen Clinics Foundation,
Revision of Problem Drug Use indicator Danica Klempová and Julián Vicente 42nd Reitox HFP meeting, 27 May 2010.
Michael Bogenschutz, Dennis Donovan, Cameron Crandall, Robert Lindblad, Raul Mandler, Harold Perl, Alyssa Forcehimes 1 Screening Procedures to Identify.
Drug and Alcohol Misuse Dr Mick McKernan. Harm Reduction Philosophy to lessen the dangers drug abuse cause to Individual/society We will never stop drug.
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
CJ411-Seminar 8 What are the major treatment strategies currently used for drug and alcohol abuse?
EMCDDA Work Programme Key Issue 1: Key Indicators 30th Meeting of Scientific Committee J Vicente (together with D Olszewski, D Klempova, L Montanari,
Zach Walsh University of British Columbia This study examined the use of cannabis as a substitute for alcohol and other psychoactive.
Hungarian data on treated drug users, 2003 József Rácz Source: Hungarian National Drug Focus Point.
EQ 2: How much money is spent on drugs? 12/3. Bell Ringer  Use the graph on the hand out  Explain what the graph is showing  What is your opinion of.
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
Austin Smith Policy & Practice Officer. Greater Glasgow & Clyde Legal Highs Monitoring Group Representatives from – Police Health Addiction Services Scottish.
Jennifer R. Havens, PhD, MPH Associate Professor
Regular and intensive use of cannabis and related problems: Some results from literature and from the 2002 REITOX reports (CT P1) Roland Simon.
EMCDDA Treatment data collection strategy - progress report May 09 Dagmar Hedrich, on behalf of the TWG Presentation at the meeting of the Scientific Committee,
TM Substance Use Transitions from Initial Use to Regular Use to Discontinuance Ralph S. Caraballo, Ph.D., MPH Office on Smoking and Health, CDC, Atlanta.
The Context and Background for Programming in Resource Constrained Settings CMBH83.
The challenge of responding to NPS injecting: A change in service provision Vicki Craik NPS and Training Coordinator.
PREVENTION OF DRUG ABUSE AMONG VULNERABLE GROUPS Dr Marcus Roberts Director of Policy and Membership DRUGSCOPE.
Situation Analysis of Drug Abuse in Pakistan Arshad Altaf, MBBS MPH Research Office Aga Khan University.
Alcohol and Drug Problem in Poland. Implications for policy Janusz Sierosławski Institute of Psychiatry i Neurology 3rd Meeting of the Expert Group on.
Measuring Substance Use
Cannabis epidemic or return of opoid problems or decrease of high risk drug use among young adults in Austria Addictions Lisbon 2017, Paper Session 2 –
MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS
World Drug Report 2018.
Non-fatal poisoning with illicit drugs in Denmark
Linn Gjersing & Anne Line Bretteville-Jensen
Managing the Homeless Street Community Effectively
Skopje, 21 November 2017, General Population Survey results– launch
Presentation transcript:

“Problem, intensive drug use and polydrug use” Introduction Danica Klempova, Scientific Committee meeting, Lisbon, 17 November

The traditional Problem drug use key indicator To look at the most harmful, heavy forms of drug use Traditionally using indirect statistical methods (multipiers, CRC, MIM) to estimate the sizes of these – largely hidden – populations To assess needs and coverage of interventions Defined by (umbrella definition) drug-type (opioids, cocaine and amphetamines) and a broadly described behavioural pattern (injecting and/or long- term and/or regular) NOT BY PROBLEMS!

Changes in the drug situation and reaction to them Changing patterns of drug use in the past 15 years (stimulants, cannabis TDI) 2004 focused small expert meeting in Sintra Reporting by drug (POU, PSU) and IDU - overlapping categories Applying instruments within general population surveys (cannabis abuse and dependence)

Discussions about concepts… Traditional PDU – trends uninterrupted Intensive, frequent, long-term, dependent, harmful, abuse…(by drug and pattern of use) Polydrug use yes, but what kind (+question of alcohol) Substitution medication – distinguished

…have to be closely related to data sources Traditional data sources for the indirect estimates; improvement of data quality Novel data sources for indirect estimates (e.g. emergency room data, …) Out-of-treatment populations – focused studies in different settings (street, LTS,..) – e.g. RDS General population surveys for cannabis intensive/long- term/dependent use (other substances with high prevalence and lower stigmatisation of use)

Starting from concepts Starting from data sources

PDU Problem opioid users Problem cocaine users Problem amphetamine users Injecting drug users

“Problem, intensive and polydrug use” Problem opioid users Problem cocaine users Problem amphetamine users Heavy/long-term cannabis users e.g. Intensive, long-term or otherwise harmful cocaine users (ILH) And, and, and… Injecting drug users

“Problem, intensive and polydrug use” Problem amphetamine users Heavy/long-term cannabis users e.g. Intensive, long-term or otherwise harmful cocaine users (ILH) Injecting drug users Problem opioid users And, and, and… Problem cocaine users